Benzodiazepine Withdrawal

What to expect when reducing or stopping benzodiazepines, why the process carries real medical risk, and why a supervised approach produces significantly better outcomes than stopping alone.

Why Benzodiazepine Withdrawal Is Medically Significant

Benzodiazepine withdrawal can be difficult, and in some cases, it needs to be managed carefully.

Symptoms can include anxiety, poor slee  and physical discomfort. In some situations – particularly if the medication is stopped suddenly or reduced too quickly – more serious symptoms like seizures can occur.

This isn’t something everyone experiences, but it is a recognised risk, which is why benzodiazepines are usually reduced gradually rather than stopped all at once.

A slower, supported reduction helps to lower risk and makes the process more manageable.

The reason is physiological. Benzodiazepines work by enhancing GABA, the brain’s primary inhibitory neurotransmitter, producing calm, reduced anxiety and sedation. With extended use, the nervous system adapts, reducing the sensitivity of GABA receptors to compensate. When the drug is removed, the nervous system – now without the GABA enhancement it has relied on – becomes hyperactive. The result is a withdrawal syndrome characterised by the opposite of the drug’s effects: anxiety, agitation, insomnia, tremor and in more severe cases, seizures.

This is why stopping benzodiazepines suddenly is not recommended under any circumstances without medical guidance, regardless of the dose or how long they have been taken.

Withdrawal Symptoms

Symptoms vary in intensity depending on the specific benzodiazepine, the dose, the duration of use and individual factors. The most commonly reported include:

  • Intense anxiety, often more severe than the anxiety the medication was originally prescribed to treat
  • Insomnia, vivid dreams, and nightmares
  • Tremor, shaking, and muscle stiffness
  • Sweating, palpitations, and elevated heart rate
  • Nausea, headaches and dizziness
  • Heightened sensitivity to light, sound, and touch
  • Difficulty concentrating and memory problems
  • Low mood and emotional flatness
  • Depersonalisation, a sense of detachment from oneself or surroundings

In more severe cases, withdrawal can involve hallucinations, confusion and seizures. These require immediate emergency medical attention.

Research suggests that between 20 and 30% of people who have been taking benzodiazepines for more than four weeks will experience significant withdrawal symptoms on reduction or cessation. The severity is not always predictable from dose or duration alone.

The Withdrawal Timeline

The timeline depends significantly on whether the benzodiazepine is short-acting or long-acting, a distinction that affects both when symptoms begin and how they progress.

Short-acting benzodiazepines — including alprazolam (Xanax), lorazepam (Ativan) and temazepam are eliminated from the body quickly. Withdrawal symptoms typically begin within one to two days of the last dose, can be more intense in their onset, and may peak earlier. Short-acting benzodiazepines are generally considered harder to withdraw from because of the rapid fluctuations in drug levels the body experiences.

Long-acting benzodiazepines — including diazepam (Valium) and clonazepam, remain in the system for longer. Withdrawal symptoms typically begin two to seven days after the last dose and develop more gradually. This slower onset is one of the reasons diazepam is commonly used as a substitution drug in supervised tapers; its long half-life produces smoother, more manageable reductions.

The acute withdrawal phase is the most intense period, and is typically described as lasting five to twenty-eight days, with symptoms peaking around two weeks. For many people, most symptoms resolve within four to six weeks. However, a significant minority experience what is known as protracted withdrawal syndrome, persistent symptoms including anxiety, insomnia, cognitive difficulties and physical sensations that can continue for months and in some cases years. Gradual improvement over six to twelve months is typical for those in protracted withdrawal, though the timeline varies considerably between individuals.

The Rebound Problem

One of the more difficult parts of benzodiazepine withdrawal is what’s often called the rebound effect.

As the medication is reduced, symptoms like anxiety and poor sleep can come back more strongly than before. This can feel confusing, especially if the medication was originally prescribed to help with those same things.

It’s not always easy to tell what’s happening. Sometimes it’s withdrawal. Sometimes it’s the underlying anxiety returning. Often, it’s a mix of both.

After being used to the medication, the body can feel unsettled without it. At the same time, any original anxiety may still need support.

This is why withdrawal can feel difficult to manage alone. With the right support and enough time, things can begin to settle and make more sense.

Getting Support for Withdrawal

Benzodiazepine withdrawal should not be managed without clinical support. The medical risks are real, the process is unpredictable, and the anxiety and distress that emerge during reduction are significantly better supported in a structured environment than alone.

Understanding what benzodiazepine detox involves, such as the clinical process, the diazepam taper, and why residential support produces better outcomes, is the right next step for anyone considering reducing or stopping.

What Happens After Withdrawal

Completing a benzodiazepine taper addresses the physical dependency. What it doesn’t address is the underlying anxiety, trauma or mental health condition for which the benzodiazepines were originally prescribed, and which tends to continue driving the same patterns.

Clinical guidance is consistent on this point: withdrawal management alone is unlikely to produce lasting change. The psychological work, such as understanding what the benzodiazepines were managing, building alternative tools for anxiety and emotional regulation, addressing any co-occurring conditions, is where recovery becomes sustainable.

For people with dual diagnosis,  when benzodiazepine dependence sits alongside another mental health condition, it’s usually more helpful to look at both together, rather than trying to deal with them one at a time.

Getting Support

If you are currently taking benzodiazepines and are concerned about dependency, or if previous attempts to reduce have not held, the most important thing is not to stop alone. The medical risks are real and the process is significantly safer with clinical support.

At Abbington House, benzodiazepine dependency is treated within our residential programme, with medically supervised detox, a supervised taper managed by our clinical team and therapeutic support for the underlying picture throughout. Our drug rehab page explains what residential treatment for prescription drug dependency involves.

If you’d like to speak to someone about your situation, you can contact our admissions team confidentially and without pressure. You don’t need to have made any decisions before reaching out.